Radiological and clinical results of longterm treatment of rheumatoid arthritis with methotrexate and azathioprine

Journal of Rheumatology

Volumn 27, Issue 5, 2000, Pages 1148-1155

  Kerstens, Pit J S M ^a,b   Boerbooms, Agnes M Th ^a   Jeurissen, Maurice E C ^a   De Graaf, Ruurd ^a   Mulder, Jan ^a   Van De Putte, Leo B A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JAN VAN BREEMEN INSTITUTE   (Netherlands)

Author keywords

Azathioprine; Longterm; Methotrexate; Radiology; Rheumatoid arthritis; Treatment

Indexed keywords

AZATHIOPRINE; METHOTREXATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; AZATHIOPRINE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0034061885     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Weinblatt ME, Coblyn JS, Fox DA, et al. Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med 1985;312:818-22.
2. Williams HJ, Willkens RF, Samuelson CO Jr, et al. Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum 1985;28:721-30.
3. Andersen PA, West SG, O'Dell JR, Via CS, Claypool RG, Kotzin BL. Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunological effects in a randomised double-blind study. Ann Intern Med 1985;103:489-96.
4. Jeurissen MEC, Boerbooms AMT, van de Putte LBA, et al. Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. A forty-eight-week randomized double-blind trial. Arthritis Rheum 1991;34:761-72.
5. Weinblatt ME, Kaplan H, Germain BF, et al. Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. A thirty-six-week, double-blind trial. Arthritis Rheum 1990;33:330-8.
6. Felson DT, Anderson JJ, Meenan RF. Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A meta-analyses of published clinical trials. Arthritis Rheum 1992;35:1117-25.
7. Weinblatt ME, Kaplan H, Germain BF, et al. Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study. Arthritis Rheum 1994;37:1492-8.
8. Kremer JM, Phelps CT. Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months. Arthritis Rheum 1992;35:138-45.
9. Pincus T, Marcum SB, Callahan LF. Long-term drug therapy for rheumatoid arthritis in seven rheumatology private practices. II. Second-line drugs and prednisone. J Rheumatol 1992.19:1885-94.
10. Wolfe F, Hawley DJ, Cathey MA. Termination of slow-acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts. J Rheumatol 1990;17:994-1002.
11. Jeurissen MEC, Boerbooms AMT, van de Putte LBA, Doesburg WH, Lemmens AM. Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis. A randomized, double-blind study. Ann Intern Med 1991;114:999-1004.
12. Ropes MW, Bennet GA, Cobb S, Jacox R, Jesser RA. Diagnostic criteria for rheumatoid arthritis: 1958 revision. Ann Rheum Dis 1959;18:49-53.
13. Ritchie DM, Boyle JA, McInnes JN, Greieveson P, Buchanan W. Clinical studies with an articular index for assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968;37:393-7.
14. van der Heijde DM, van't Hof MA, van Riel PL, Theunisse HA, Lubberts EW, van de Putte LBA. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a "disease activity score." Ann Rheum Dis 1990;49:906-9.
15. Sharp JT, Young DY, Bluhm GB, et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 1985;28:1326-35.
16. van der Heijde DMFM, van Riel PLCM, Nuver-Zwart IH, Gribnau FWJ, van de Putte LBA. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;1:1036-8.
17. Kerstens PJSM, van Loenhout JWA, Boerbooms AMT, van de Putte LBA. Methotrexate, pneumonitis and infection [letter]. Ann Rheum Dis 1992;51:1179.
18. Jeurissen MEC, Boerbooms AMT, van de Putte LBA. Eruption of nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis. Clin Rheumatol 1989;8:418-9.
19. Jeurissen MEC, Boerbooms AMT, van de Putte LBA. Pancytopenia related to azathioprine in rheumatoid arthritis. Ann Rheum Dis 1988;47:503-5.
20. Kerstens PJSM, Stolk JN, De Abreu RA, Lambooy LHJ, van de Putte LBA, Boerbooms AMT. Azathioprine-related bone marrow toxicity and low activities of purine enzymes in patients with rheumatoid arthritis. Arthritis Rheum 1995;38:142-5.
21. Pincus T, Callahan LF, Brooks RH, Fuchs HA, Olsen NJ, Kaye JJ. Self-report questionnaire scores in rheumatoid arthritis compared with traditional physical, radiographic and laboratory measures. Ann Intern Med 1989;110:259-66.
22. Kremer JN, Lee JK. A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Update after a mean of fiftythree months. Arthritis Rheum 1988;31:577-84.
23. Weinblatt ME, Trentham DE, Fraser PA, et al. Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis. Arthritis Rheum 1988;31:167-75.
24. Hanrahan PS, Scrivens GA, Russell AS. Prospective long-term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiologic progression. Br J Rheumatol 1989;28:147-53.
25. Sany J, Kaliski S, Couret M, Cuchacovich M, Daures J-P. Radiologic progression during intramuscular methotrexate treatment of rheumatoid arthritis. J Rheumatol 1990;17:1636-41.
26. Nordstrom DM, West SG, Andersen PA, Sharp JT. Pulse methotrexate therapy in rheumatoid arthritis. A controlled prospective roentgenographic study. Ann Intern Med 1987;107:797-801.
27. Reykdal S, Steinsson K, Sigurjonsson K, Brekkan A. Methotrexate treatment of rheumatoid arthritis: effects on radiologie progression. Scand J Rheumatol 1989;18:221-6.
28. Winfield J, Young A, Williams P, Corbett M. Prospective study of the radiological changes in hands, feet and cervical spine in adult rheumatoid disease. Ann Rheum Dis 1983;42:613-8.
29. Gofton JP, O'Brien W, Hurley JN, Scheffer BJ. Radiographic evaluation of erosion in rheumatoid arthritis: double blind study of auranofin vs placebo. J Rheumatol 1984;11:768-71.
30. Rau R, Herborn G, Karger Th, Menninger H, Elhardt D, Schmitt J. A double blind randomized parallel trial of intramuscular methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis. J Rheumatol 1991;18:328-33.
31. Rau R, Herborn G, Menninger H, Sangha O. Progression in early erosive rheumatoid arthritis: 12 month results from a randomized controlled trial comparing methotrexate and gold sodium thiomalate. Br J Rheumatol 1998;37:1220-6.
32. Lopez-Mendez A, Daniel WW, Reading JC, Ward JR, Alarcon GS. Radiographic assessment of disease progression in rheumatoid arthritis patients enrolled in the cooperative studies of the rheumatic diseases program randomized clinical trial of methotrexate, auranofin or a combination of the two. Arthritis Rheum 1993;36:1364-9.
33. Weinblatt ME, Polisson R, Blotner SD, et al. The effects of drug therapy on radiographic progression of rheumatoid arthritis. Results of a 36-week randomized trial comparing methotrexate and auranofin. Arthritis Rheum 1993;36:613-9.
34. Hamdy H, McKendry RJR, Mierins E, Liver JA. Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A twenty-four-week controlled clinical trial. Arthritis Rheum 1987;30:361-8.
35. Alarcon GS, Lopez-Mendez A, Walter J. et al. Radiographic evidence ot disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis. J Rheumatol 1992;19:1868-73.
36. Drosos AA, Tsifetaki N, Tsiakou EK, et al. Influence of methotrexate on radiographic progression in rheumatoid arthritis: a sixty-month prospective study. Clin Exp Rheumatol 1997;15:263-7.
37. Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 1995;333:142-6.
38. Furst DE, Koehnke R, Burmeister LE, Kohler J, Cargill I. Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis. J Rheumatol 1989;16:313-20.
39. Morand EF, McCloud PI, Littlejohn GO. Life table analysis of 879 treatment episodes with slow acting antirheumatic drugs in community rheumatology practice. J Rheumatol 1992;19:704-8.
40. Buchbinder R, Hall S, Sambrook PN, et al. Methotrexate therapy in rheumatoid arthritis: a life table review of 587 patients treated in community practice. J Rheumatol 1993;20:639-44.
41. Kerstens PJSM, Stolk JN, Boerbooms AMT, De Abreu RA, van de Putte LBA. Purine enzymes in rheumatoid arthritis. A clue to the prediction of the response to azathioprine? Review and hypothesis. Clin Exp Rheumatol 1995;13:107-11.
42. Kerstens PJSM, Stolk JN, Boerbooms AMT, et al. Purine enzymes in rheumatoid arthritis: possible association with response to azathioprine. A pilot study. Ann Rheum Dis 1994;53:608-11.